VELIN-PHARMA A/S: Financial statements 2026
CVR: 33026013
Source: annual report 2026, Danish Business Authority
01/06/2025 – 31/05/2026
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 33,996 and a net result of DKK -4,856,473 compared with DKK -16,021,366 the year before. That is a decrease of 64.2% compared with the year before. Equity in the 2026 report amounted to DKK 28,606,185. The solvency ratio was 90.1%.
- Gross Profit
- DKK 33,996
- Profit/Loss
- DKK -4,856,473
- Equity
- DKK 28,606,185
- Total Assets
- DKK 31,764,275
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 34K | -4.9M | 28.6M | 0 |
| 2025 | - | 95K | -16M | 33.5M | 0 |
| 2024 | - | -3K | 12.7M | 49.5M | 0 |
| 2023 | - | 161K | 5.5M | 36.8M | 0 |
| 2022 | - | 440K | 3.1M | 31.2M | 0 |
Official annual report
Find more companies like VELIN-PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 33,996 and a net result of DKK -4,856,473 compared with DKK -16,021,366 the year before. Equity in the 2026 report amounted to DKK 28,606,185.
